(1)
Dr. Reddy s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY along with its subsidiaries together referred to as Dr. Reddy s ) today announced that it has initiated the process with the Drugs Controller General of India (DCGI) for Emergency Use Authorization (EUA) of the well-studied human adenoviral vector-based platform vaccine candidate, Sputnik V.
As part of the review process, Dr. Reddy s will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete by 21
st February 2021.
In September 2020, Dr. Reddy s partnered with the Russian Direct Investment Fund (RDIF) to conduct the clinical trials of the Sputnik V and for its distribution rights in India. The vaccine is currently undergoing the phase 3 clinical trial in India. Sputnik V has demonstrated an efficacy rate of 91.6% in the interim analysis of the phase 3 clinical trial, which included data on 19,866 volunteers in Russia, who rec
Dynavax Announces European Commission Marketing Authorization for HEPLISAV B, a 2 Dose Adult Hepatitis B Adjuvanted Vaccine Approval based on safety and immunogenicity results from three Phase 3 clinical trials Statistically significantly higher and faster rates of protection and similar safety compared to Engerix-B in all 3 trials HEPLISAV B is the only 2-dose adult hepatitis B vaccine offering protection in just 1 month
EMERYVILLE, Calif., Feb. 19, 2021 /PRNewswire/ Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that the European Commission (EC) has granted Marketing Authorization for HEPLISAV B (Hepatitis B Vaccine (Recombinant), Adjuvanted) for the active immunization against hepatitis B virus infection (HBV) caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The approval was issued following the European Medicines Agency (EMA)
Isigny Sainte-Mère Dairy Cooperative receives accreditation for infant formula milk powder testing laboratory The Isigny Sainte-Mère milk powder testing laboratory in France has recently received COFRAC ISO 17025 accreditation.
This standard, rarely obtained for an infant milk testing laboratory, is issued by the COFRAC (French Accreditation Committee), the only reference accreditation body in France. It validates and guarantees the cooperative’s high level of technical competence.
Every year, Isigny Sainte-Mère produces a large quantity of infant milk powders. Due to the sensitive nature of infants, the quality of these food products needs to be faultless, the cooperative said.
Half London councils found using Chinese surveillance tech linked to Uyghur abuses theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.
Family seeks âline-of-dutyâ recognition for DC officer who died by suicide after Capitol riot By CNN Staff | February 18, 2021 at 10:51 AM EST - Updated February 18 at 11:04 AM
(CNN) â Two police officers in Washington, D.C., took their own lives after responding to last monthâs Capitol insurrection.
Now, one officerâs family is pushing for him to be recognized as someone who died in the line of duty.
Newly released audio reveals the panic of D.C. police officers who confronted the violent mob at the Capitol.
Days later, after the violence died down, two officers who responded on Jan. 6 killed themselves.